PMID: 16506354Mar 2, 2006Paper

Monte Carlo simulation in the evaluation of susceptibility breakpoints: predicting the future: insights from the society of infectious diseases pharmacists

Pharmacotherapy
Paul G Ambrose

Abstract

Appropriate treatment with antimicrobials involves factors we cannot control. Factors such as interpatient variability in drug exposure, the minimum inhibitory concentration (MIC) of the infecting pathogen, and the patient's clinical status clearly affect the therapeutic response. Despite these uncertainties, we can estimate the probability of attaining a successful therapeutic outcome in the context of factors that are within our control. Chief among these are drug, dose, and the dosing interval. One way to predict the probability of a positive therapeutic outcome is through the use of an integrated pharmacokinetic-pharmacodynamic stochastic model. Pharmacokinetic-pharmacodynamic target attainment analyses using Monte Carlo simulation to integrate interpatient variability in drug exposure, drug potency, and in vivo exposure targets predictive of positive therapeutic outcomes are influencing antibacterial susceptibility breakpoints at home and abroad. The consequences of this paradigm shift are far reaching, affecting the commercial concerns of drug and susceptibility testing device manufacturers, perceptions about antimicrobial resistance, and ultimately patient care decisions.

References

Jan 24, 1998·JAMA : the Journal of the American Medical Association·S L PrestonM Corrado
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D L Paterson, V L Yu
Jan 9, 2004·Infectious Disease Clinics of North America·Johan W Mouton

❮ Previous
Next ❯

Citations

Jul 17, 2007·Clinical Microbiology Reviews·John Turnidge, David L Paterson
Jun 30, 2009·Theoretical Biology & Medical Modelling·Goue Denis Gohore BiFahima Nekka
Jul 31, 2013·The Veterinary Clinics of North America. Small Animal Practice·Mark G Papich
Aug 28, 2012·International Journal of Antimicrobial Agents·Eduardo AsínAlicia Rodríguez Gascón
Mar 29, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Johan W MoutonJohn Turnidge
Feb 22, 2011·Enfermedades infecciosas y microbiología clínica·Lorenzo Aguilar, Juan José Granizo
Apr 13, 2010·Enfermedades infecciosas y microbiología clínica·Rafael Cantón
Apr 13, 2010·Enfermedades infecciosas y microbiología clínica·Francisco Soriano-García
Dec 17, 2008·Diagnostic Microbiology and Infectious Disease·Paul G AmbroseEvelyn Ellis-Grosse
Mar 14, 2007·Diagnostic Microbiology and Infectious Disease·C Andrew DeRykeDavid P Nicolau
Jul 16, 2008·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Kazuro IkawaTaijiro Sueda
Feb 8, 2016·British Journal of Clinical Pharmacology·J G Coen van HasseltPiet H van der Graaf
Aug 6, 2014·Antimicrobial Agents and Chemotherapy·Tawanda GumboHelen McIlleron
May 9, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·David S Burgess, Robert P Rapp

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Paul G AmbroseG L Drusano
Clinical Microbiology Reviews
J D Turnidge, David L Paterson
© 2021 Meta ULC. All rights reserved